Treatment topical with silver nanoparticles and Stryphnodendron Adstringens (Mart.) Coville in cervical lesions: randomized clinical trial.

Autor: Nascimento CA, Santos ACMD, Silva DMD, Barbosa NR, Moura EL, Silva VBD, Balliano TL, Figueiredo EVMS, Farias KF, Pitta GBB
Jazyk: angličtina
Zdroj: Revista da Escola de Enfermagem da U S P [Rev Esc Enferm USP] 2023 Jul 28; Vol. 57, pp. e20220338. Date of Electronic Publication: 2023 Jul 28 (Print Publication: 2023).
DOI: 10.1590/1980-220X-REEUSP-2022-0338en
Abstrakt: Objective: To assess the feasibility of incorporating technology as a new alternative for treating topics on cervical lesions.
Method: This is a randomized, double-blind, controlled clinical trial with a prospective design. During the realization of this study, 43 women were included and divided between groups A (ointment without silver nanoparticles n = 23) and B (ointment with silver nanoparticles n = 20) clinically healthy and who used the unified health system.
Results: There were no significant differences when comparing before and after the use of ointment for IVA test (p = 0.15), Schiller test (p = 0.15), cellular changes (p = 0.47) and microbiological analysis (p = 0.89) through cytology. After use, no adverse reaction was observed in the sample studied.
Conclusion: Based on the results identified in this study, identified that the product is safe and does not promote adverse events. Regarding the effectiveness of the product in uterine cervical lesions, it is necessary to continue the study in phase II. Registro de Ensaios Clínicos Brasileiros: UTN: U1111-1218-2820.
Databáze: MEDLINE